4.3 Review

Mesenchymal Migration as a Therapeutic Target in Glioblastoma

Journal

JOURNAL OF ONCOLOGY
Volume 2010, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2010/430142

Keywords

-

Categories

Funding

  1. National Health and Medical Research Council (NHMRC) [512251, 632515]
  2. NSW Cancer Council
  3. University of Sydney
  4. Oncology Children's Foundation

Ask authors/readers for more resources

Extensive infiltration of the surrounding healthy brain tissue is a cardinal feature of glioblastomas, highly lethal brain tumors. Deep infiltration by the glioblastoma cells renders complete surgical excision difficult and contemporary adjuvant therapies have had little impact on long-termsurvival. Thus, deep infiltration and resistance to irradiation and chemotherapy remain a major cause of patientmortality. Modern therapies specifically targeted to this unique aspect of glioblastoma cell biology hold significant promise to substantially improve survival rates for glioblastoma patients. In the present paper, we focus on the role of adhesion signaling molecules and the actin cytoskeleton in the mesenchymal mode of motility that characterizes invading glioblastoma cells. We then review current approaches to targeting these elements of the glioblastoma cell migration machinery and discuss other aspects of cell migration that may improve the treatment of infiltrating glioblastoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available